L?wa A, Budt M, Balázs A, Sikora V, Melzer M, Rubi. Clade 2.3.4.4b H5N1 influenza A virus exhibits high infectivity in human respiratory tract models. J Infect. 2026 Mar 12:106722
We read with great interest the recent letter by Li and colleagues reporting the emergence of mammalian-adapted clade 2.3.4.4b H5N1 viruses carrying the PB2-E627K mutation in migratory birds at Qinghai Lake. The identification of this canonical mammalian-adaptation marker in avian reservoirs has further intensified concerns regarding progressive viral adaptation and the potential for increased human-to-human transmission, thereby elevating pandemic risk.
The expanding host range of clade 2.3.4.4b viruses, now including poultry, dairy cattle and other mammals since early 2024, underscores their dynamic evolution and increasing interface with human populations, providing repeated opportunities for cross-species transmission and human exposure. Although most human infections have been mild, severe and fatal cases have been reported,2 underscoring the need for refined, functionally informed risk assessment approaches. In mammalian isolates, adaptive substitutions in the viral polymerase, most prominently PB2-E627K but also alternative changes such as PB2-M631L, have been associated with enhanced replication efficiency and pathogenicity. Experimental infection studies in nonhuman primates further demonstrate that clade 2.3.4.4b viruses can cause severe and sometimes lethal respiratory disease. However, whether currently circulating clade 2.3.4.4b viruses require the acquisition of PB2-E627K to exhibit substantial pathogenicity in human respiratory tissues remains unresolved.
The expanding host range of clade 2.3.4.4b viruses, now including poultry, dairy cattle and other mammals since early 2024, underscores their dynamic evolution and increasing interface with human populations, providing repeated opportunities for cross-species transmission and human exposure. Although most human infections have been mild, severe and fatal cases have been reported,2 underscoring the need for refined, functionally informed risk assessment approaches. In mammalian isolates, adaptive substitutions in the viral polymerase, most prominently PB2-E627K but also alternative changes such as PB2-M631L, have been associated with enhanced replication efficiency and pathogenicity. Experimental infection studies in nonhuman primates further demonstrate that clade 2.3.4.4b viruses can cause severe and sometimes lethal respiratory disease. However, whether currently circulating clade 2.3.4.4b viruses require the acquisition of PB2-E627K to exhibit substantial pathogenicity in human respiratory tissues remains unresolved.
See Also:
Latest articles in those days:
- The evolution and transmission dynamics of H3N2 influenza virus identified in a respiratory disease outbreak in companion dogs in Alabama, USA 6 hours ago
- Structural and functional characterization of hemagglutinin E190D and Q226H minor variants in human H5N1 A/British Columbia/PHL-2032/2024 6 hours ago
- Spatial risk factors associated with outbreaks of highly pathogenic avian influenza in Pennsylvania’s commercial poultry farms 6 hours ago
- [preprint]H9N2 avian influenza virus in Bangladesh: three genetically distinct co-circulating subgroups retain a largely conserved antigenic phenotype 6 hours ago
- [preprint]Endogenous serine proteases in MDCK sublines support trypsin-independent influenza A virus replication 6 hours ago
[Go Top] [Close Window]


